|
Volumn 99, Issue 9, 2002, Pages 872-873
|
Five experts interviewed about drugs. Benefits for the patients could have been more emphasized;Fem experter intervjuade om läkemedel. Nyttan för patienten kunde ha betonats mer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
COST BENEFIT ANALYSIS;
COST CONTROL;
DRUG COST;
DRUG UTILIZATION;
ECONOMICS;
HUMAN;
PATIENT COMPLIANCE;
POLYPHARMACY;
PRESCRIPTION;
SWEDEN;
TREATMENT OUTCOME;
COST SAVINGS;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
DRUG UTILIZATION;
HUMANS;
PATIENT COMPLIANCE;
POLYPHARMACY;
PRESCRIPTIONS, DRUG;
SWEDEN;
TREATMENT OUTCOME;
|
EID: 0037187076
PISSN: 00237205
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|